IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation
Authors:
Open Access
- 17 April 2014
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3661
Abstract
Lack of cellular differentiation is a key feature of nasopharyngeal carcinoma (NPC), but it also presents as a unique opportunity for intervention by differentiation therapy. Here using RNA-seq profiling analysis and functional assays, we demonstrate that reduced IKKα expression is responsible for the undifferentiated phenotype of NPC. Conversely, overexpression of IKKα induces differentiation and reduces tumorigenicity of NPC cells without activating NF-κB signalling. Importantly, we describe a mechanism whereby EZH2 directs IKKα transcriptional repression via H3K27 histone methylation on the IKKα promoter. The differentiation agent, retinoic acid, increases IKKα expression by suppressing EZH2-mediated H3K27 histone methylation, resulting in enhanced differentiation of NPC cells. In agreement, an inverse correlation between IKKα (low) and EZH2 (high) expression is associated with a lack of differentiation in NPC patient samples. Collectively, these findings demonstrate a role for IKKα in NPC differentiation and reveal an epigenetic mechanism for IKKα regulation, unveiling a new avenue for differentiation therapy.Keywords
This publication has 54 references indexed in Scilit:
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group StudyJournal of Clinical Oncology, 2009
- Acute promyelocytic leukemia: from highly fatal to highly curableBlood, 2008
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolBlood, 2002
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB KinaseScience, 1999
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- Prognostic significance of keratinization in nasopharyngeal carcinomaAmerican Journal of Otolaryngology, 1995
- Acute promyelocytic leukemia: treatment results during a decade at Memorial HospitalBlood, 1989
- Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patientsBlood, 1988